An observational study in Rare Diseases, sponsored by Imagine Institute. Recruiting at 1 site in France. Open to participants aged 15 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-04-14.
Sponsored by Imagine Institute · Observational
Rare diseases are often synonymous with difficulties for sufferers, whether physical, mental or social. Patients suffering from rare diseases face specific problems, such as the long wait for a diagnosis, the geographical distance between the rare disease reference center and home, and the isolation created by this very disabling disease... Children suffering from rare genetic diseases have difficulty accessing higher education, but above all in finding an internship or work-study placement, due to the rarity of their disability.
The aim of this study, entitled "Imagine La Suite", is to assess the difficulties encountered by young people with rare genetic diseases and disabilities in their search for vocational and university training or employment.
Patients currently aged 15-25 born between 1997 and 2007 and followed at Necker in the networks of the following disease reference centers:
Rare genetic disease confirmed by a genetic test, originating in childhood and followed at Necker in the networks of the following disease reference centers:
Exclusion Criteria:
Patients take part in a survey, completing a form in less than 30 minutes
Entry into a training program, validation of a diploma, obtaining a 1st stable job
Time frame: 18 Months
Characterize the pathology components of the care pathway, barriers/ strengths to inclusion
Time frame: 18 Months
Use of tools to facilitate socio-professional inclusion
Time frame: 18 Months
Number of HR company representatives made aware of rare diseases
Time frame: 18 Months
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Imagine Institute